New Search

If you are not happy with the results below please do another search

2034 search results for:

1511

Blood biomarkers in drug-resistant cancer tumour cells

While searching for  a non-invasive way to detect prostate cancer cells circulating in blood, Duke Cancer Institute researchers have identified some blood markers associated with tumour resistance to two common hormone therapies. In a study, the Duke-led team reported that they isolated multiple key gene alterations in the circulating prostate tumour cells of patients who […]

1512

New rapid gene test for mitochondrial disease

Newcastle researchers have developed a genetic test providing a rapid diagnosis of mitochondrial disorders to identify the first patients with inherited mutations in a new disease gene. The team of medics and scientists at the Wellcome Trust Centre for Mitochondrial Research at Newcastle University, together with international collaborators, have identified mutations in a gene, known […]

1513

Your viruses could reveal your travel history, and more

The genomes of two distinct strains of the virus that causes the common lip cold sore, herpes simplex virus type 1 (HSV-1), have been identified within an individual person — an achievement that could be useful to forensic scientists for tracing a person’s travel history. The research also opens the door to understanding how a […]

1514

Diagnosis of Alzheimer’s disease: llama antibodies detect cerebral lesions

Alzheimer’s disease is characterized by two types of cerebral lesion: amyloid plaques and neurofibrillary tangles. Amyloid beta peptide (Aβ), naturally present in the brain, builds up over the years as a result of genetic and environmental factors until it forms amyloid plaques. This build-up is toxic for nerve cells: it leads to a loss of […]

1515

SCIEX University accessible online for MS users

SCIEX University is a new online service launched by SCIEX for its mass spectrometry customers. Designed as a new way to master workflows, SCIEX University is powered by a robust learning management system and features a new look and feel. A personalized dashboard allows the user to see all training records, certifications and enrol in […]

1516

GeT online – the new microsite from Greiner Bio-One

Under the banner “GeT Perfect”, Greiner Bio-One has kicked off the European promotion of the Greiner eHealth Technologies Solution – GeT.  For this purpose, a modern microsite in German and English has been created.  The one page site provides all essential information at a glance. GeT utilizes a flexible modular based software solution whilst applying […]

1517

Thermo Fisher Scientific partners with HEALTH BioMed to support molecular diagnostics development in China

Thermo Fisher Scientific and HEALTH BioMed (HBM) have announced a collaboration to support HBM’s development of molecular diagnostic (MDx) kits for infectious disease and pharmacogenomics screening to serve the China market. Under the terms of a strategic agreement, HBM will submit all kits it develops on the Applied Biosystems 3500Dx Capillary Electrophoresis (CE) platform through […]

1518

Prostate cancer study may lead to new diagnostic tests and treatments

Prostate cancer patients have been offered hope after scientists at Newcastle University have identified a new group of molecules that could be targeted to slow tumour growth. Our findings are very significant for future treatments as they identify a new group of molecules in prostate cancer which could be targeted therapeutically.  Experts used an advanced […]

1519

Genomic makeup of colorectal cancers predicts immune system ability to fight tumours

Genomic makeup of colorectal cancers predicts immune system ability to fight tumours Colorectal cancers heavily bedecked with tumour-related proteins called neoantigens are likely to be permeated with disease-fighting white blood cells, researchers at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard report in a new study. Because such an influx of white […]

1520

Expression of specific gene differentiates moles from melanoma

Most melanomas are driven by mutations that spur out-of-control cell replication, while nevi (moles composed of non-cancerous cells at the skin surface) harbouring the same mutations do not grow wildly. However, changes in the level of gene expression can cause nevi to become melanomas. Dermatologists surmise that 30 to 40 percent of melanomas (approximately 30,000 […]